Use of obinutuzumab in clinical practice – case report
MUDr. Mária Maco
Interní hematologická klinika 3. LF UK a FNKV, Praha
Obinutuzumab with bendamustine is currently used for the treatment of follicular lymphoma in patients who are refractory to rituximab alone or to combination of chemotherapy with rituximab. This case report describes a successful treatment with obinutuzumab and bendamustine followed by obinutuzumab maintenance in a patient with multiple relapses of follicular lymphoma after several treatment lines with rituximab.
follicular lymphoma, obinutuzumab, bendamustine, refractory lymphoma
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...